← Back to patent-cliff list
CAS 2180923-72-0
tert-Butyl 4-[4-(ethoxycarbonyl)-3-[(1H-pyrrolo[2,3-b]pyridin-5-yl)oxy]phenyl]piperazine-1-carboxylate
Codes: (XXIV)992511-1-c
Application context (from source-drug indications)
Chronic lymphocytic leukaemiaLisaftoclaxAcute promyelocytic leukaemiaLisaftoclaxMyelodysplastic syndromeLisaftoclaxAcute myeloid leukaemiaLisaftoclaxDiffuse large B-cell lymphomaLisaftoclaxSystemic lupus erythematosusLisaftoclax
Source drugs (routes using this intermediate)
| Drug | Tier | Expiry |
|---|---|---|
| Lisaftoclax | Tier C — Watch / trade | - |
Position in synthesis routes (up/downstream chain)
Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.
Ethyl 2-((1H-pyrrolo[2,3-b]pyridin-5-yl)oxy)-4-(piperazin-1 -yl)benzoate→Ethyl 2,4-difluorobenzoate→1-(Triisopropylsilyl)-1H-pyrrolo[2,3-b]pyridin-5-ol→Ethyl 2-((1H-pyrrolo[2,3-b]pyridin-5- yl)oxy)-4-fluorobenzoate→1-(1,1-Dimethylethoxycarbonyl)piperazine→tert-Butyl 4-[4-(ethoxycarbonyl)-3-[(1H-pyrrolo[2,3-b]pyridin-5-yl)oxy]phenyl]piperazine-1-carboxylate
Intermediates available on this site
No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.
This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.